Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 37 to 48 of 165 entries
Sorted by: Best Match Show Resources per page
Filters applied: Corrected and Republished Article
Corrigendum: A Pharmacogenomic-based Antidepressant Treatment for Patients with Major Depressive Disorder: Results from an 8-week, Randomized, Single-blinded Clinical Trial.

Clinical psychopharmacology and neuroscience : the official scientific journal of the Korean College of Neuropsychopharmacology

Han C, Wang SM, Bahk WM, Lee SJ, Patkar AA, Masand PS, Mandelli L, Pae CU, Serretti A.
PMID: 33124599
Clin Psychopharmacol Neurosci. 2020 Nov 30;18(4):641. doi: 10.9758/cpn.2020.18.4.641.

No abstract available.

Cite
Han C, Wang SM, Bahk WM, et al. Corrigendum: A Pharmacogenomic-based Antidepressant Treatment for Patients with Major Depressive Disorder: Results from an 8-week, Randomized, Single-blinded Clinical Trial. Clin Psychopharmacol Neurosci. 2020;18(4):641doi: 10.9758/cpn.2020.18.4.641.
Han, C., Wang, S. M., Bahk, W. M., Lee, S. J., Patkar, A. A., Masand, P. S., Mandelli, L., Pae, C. U., & Serretti, A. (2020). Corrigendum: A Pharmacogenomic-based Antidepressant Treatment for Patients with Major Depressive Disorder: Results from an 8-week, Randomized, Single-blinded Clinical Trial. Clinical psychopharmacology and neuroscience : the official scientific journal of the Korean College of Neuropsychopharmacology, 18(4), 641. https://doi.org/10.9758/cpn.2020.18.4.641
Han, Changsu, et al. "Corrigendum: A Pharmacogenomic-based Antidepressant Treatment for Patients with Major Depressive Disorder: Results from an 8-week, Randomized, Single-blinded Clinical Trial." Clinical psychopharmacology and neuroscience : the official scientific journal of the Korean College of Neuropsychopharmacology vol. 18,4 (2020): 641. doi: https://doi.org/10.9758/cpn.2020.18.4.641
Han C, Wang SM, Bahk WM, Lee SJ, Patkar AA, Masand PS, Mandelli L, Pae CU, Serretti A. Corrigendum: A Pharmacogenomic-based Antidepressant Treatment for Patients with Major Depressive Disorder: Results from an 8-week, Randomized, Single-blinded Clinical Trial. Clin Psychopharmacol Neurosci. 2020 Nov 30;18(4):641. doi: 10.9758/cpn.2020.18.4.641. PMID: 33124599; PMCID: PMC7609217.
Copy Download .nbib Format: NLM
Fast gas chromatography analysis of N-carbamates with cold on-column injection.

Journal of chromatographic science

Song X, McNair HM.
PMID: 12201475
J Chromatogr Sci. 2002 Aug;40(7):321-5. doi: 10.1093/chromsci/40.7.321.

Direct gas chromatographic (GC) analysis of thermally labile N-carbamates is studied by using fast GC with cold on-column injection. With the greatly reduced injection temperature, short column lengths, high flow rate, and fast temperature-programming rate, the exposure of carbamates...

Cite
Song X, McNair HM. Fast gas chromatography analysis of N-carbamates with cold on-column injection. J Chromatogr Sci. 2002;40(7):321-5doi: 10.1093/chromsci/40.7.321.
Song, X., & McNair, H. M. (2002). Fast gas chromatography analysis of N-carbamates with cold on-column injection. Journal of chromatographic science, 40(7), 321-5. https://doi.org/10.1093/chromsci/40.7.321
Song, Xiling, and McNair, Harold M. "Fast gas chromatography analysis of N-carbamates with cold on-column injection." Journal of chromatographic science vol. 40,7 (2002): 321-5. doi: https://doi.org/10.1093/chromsci/40.7.321
Song X, McNair HM. Fast gas chromatography analysis of N-carbamates with cold on-column injection. J Chromatogr Sci. 2002 Aug;40(7):321-5. doi: 10.1093/chromsci/40.7.321. PMID: 12201475.
Copy Download .nbib Format: NLM
The future generation.

Journal of the Mississippi State Medical Association

Davis JT.
PMID: 2291766
J Miss State Med Assoc. 1990 Dec;31(12):414-6.

No abstract available.

Cite
Davis JT. The future generation. J Miss State Med Assoc. 1990;31(12):414-6
Davis, J. T. (1990). The future generation. Journal of the Mississippi State Medical Association, 31(12), 414-6.
Davis, J T. "The future generation." Journal of the Mississippi State Medical Association vol. 31,12 (1990): 414-6.
Davis JT. The future generation. J Miss State Med Assoc. 1990 Dec;31(12):414-6. PMID: 2291766.
Copy Download .nbib Format: NLM
2017 National Standards for Diabetes Self-Management Education and Support.

The Diabetes educator

Beck J, Greenwood DA, Blanton L, Bollinger ST, Butcher MK, Condon JE, Cypress M, Faulkner P, Fischl AH, Francis T, Kolb LE, Lavin-Tompkins JM, MacLeod J, Maryniuk M, Mensing C, Orzeck EA, Pope DD, Pulizzi JL, Reed AA, Rhinehart AS, Siminerio L, Wang J.
PMID: 30558523
Diabetes Educ. 2019 Feb;45(1):34-49. doi: 10.1177/0145721718820941. Epub 2018 Dec 17.

PURPOSE: The purpose of this study is to review the literature for Diabetes Self-Management Education and Support (DSMES) to ensure the National Standards for DSMES (Standards) align with current evidence-based practices and utilization trends.METHODS: The 10 Standards were divided...

Cite
Beck J, Greenwood DA, Blanton L, et al. 2017 National Standards for Diabetes Self-Management Education and Support. Diabetes Educ. 2018;45(1):34-49doi: 10.1177/0145721718820941.
Beck, J., Greenwood, D. A., Blanton, L., Bollinger, S. T., Butcher, M. K., Condon, J. E., Cypress, M., Faulkner, P., Fischl, A. H., Francis, T., Kolb, L. E., Lavin-Tompkins, J. M., MacLeod, J., Maryniuk, M., Mensing, C., Orzeck, E. A., Pope, D. D., Pulizzi, J. L., Reed, A. A., Rhinehart, A. S., Siminerio, L., & Wang, J. (2019). 2017 National Standards for Diabetes Self-Management Education and Support. The Diabetes educator, 45(1), 34-49. https://doi.org/10.1177/0145721718820941
Beck, Joni, et al. "2017 National Standards for Diabetes Self-Management Education and Support." The Diabetes educator vol. 45,1 (2019): 34-49. doi: https://doi.org/10.1177/0145721718820941
Beck J, Greenwood DA, Blanton L, Bollinger ST, Butcher MK, Condon JE, Cypress M, Faulkner P, Fischl AH, Francis T, Kolb LE, Lavin-Tompkins JM, MacLeod J, Maryniuk M, Mensing C, Orzeck EA, Pope DD, Pulizzi JL, Reed AA, Rhinehart AS, Siminerio L, Wang J. 2017 National Standards for Diabetes Self-Management Education and Support. Diabetes Educ. 2019 Feb;45(1):34-49. doi: 10.1177/0145721718820941. Epub 2018 Dec 17. PMID: 30558523.
Copy Download .nbib Format: NLM
Ciprofloxacin Otic Suspension (Otiprio) for Acute Otitis Externa.

JAMA

[No authors listed]
PMID: 30285176
JAMA. 2018 Oct 02;320(13):1375-1376. doi: 10.1001/jama.2018.12787.

No abstract available.

Cite
Ciprofloxacin Otic Suspension (Otiprio) for Acute Otitis Externa. JAMA. 2018;320(13):1375-1376doi: 10.1001/jama.2018.12787.
(2018). Ciprofloxacin Otic Suspension (Otiprio) for Acute Otitis Externa. JAMA, 320(13), 1375-1376. https://doi.org/10.1001/jama.2018.12787
"Ciprofloxacin Otic Suspension (Otiprio) for Acute Otitis Externa." JAMA vol. 320,13 (2018): 1375-1376. doi: https://doi.org/10.1001/jama.2018.12787
Ciprofloxacin Otic Suspension (Otiprio) for Acute Otitis Externa. JAMA. 2018 Oct 02;320(13):1375-1376. doi: 10.1001/jama.2018.12787. PMID: 30285176.
Copy Download .nbib Format: NLM
A Multicenter, Prospective, Randomized Controlled Trial Evaluating the Efficacy of Rectal Diclofenac and Sublingual Nitrate as a Combined Prophylactic Treatment for Post-ERCP Pancreatitis.

Acta medica Okayama

Tomoda T, Kato H, Mizukawa S, Muro S, Akimoto Y, Uchida D, Matsumoto K, Yamamoto N, Horiguchi S, Tsutsumi K, Okada H.
PMID: 28824193
Acta Med Okayama. 2017 Aug;71(4):357-362. doi: 10.18926/AMO/55314.

Acute pancreatitis is the major complication of endoscopic retrograde cholangiopancreatography(ERCP). A preliminary research suggested that the administration of nonsteroidal anti-inflammatory drugs (NSAIDs) with nitrate might reduce the incidence of post-ERCP pancreatitis (PEP) more effectively than NSAIDs alone. We conduct...

Cite
Tomoda T, Kato H, Mizukawa S, et al. A Multicenter, Prospective, Randomized Controlled Trial Evaluating the Efficacy of Rectal Diclofenac and Sublingual Nitrate as a Combined Prophylactic Treatment for Post-ERCP Pancreatitis. Acta Med Okayama. 2017;71(4):357-362doi: 10.18926/AMO/55314.
Tomoda, T., Kato, H., Mizukawa, S., Muro, S., Akimoto, Y., Uchida, D., Matsumoto, K., Yamamoto, N., Horiguchi, S., Tsutsumi, K., & Okada, H. (2017). A Multicenter, Prospective, Randomized Controlled Trial Evaluating the Efficacy of Rectal Diclofenac and Sublingual Nitrate as a Combined Prophylactic Treatment for Post-ERCP Pancreatitis. Acta medica Okayama, 71(4), 357-362. https://doi.org/10.18926/AMO/55314
Tomoda, Takeshi, et al. "A Multicenter, Prospective, Randomized Controlled Trial Evaluating the Efficacy of Rectal Diclofenac and Sublingual Nitrate as a Combined Prophylactic Treatment for Post-ERCP Pancreatitis." Acta medica Okayama vol. 71,4 (2017): 357-362. doi: https://doi.org/10.18926/AMO/55314
Tomoda T, Kato H, Mizukawa S, Muro S, Akimoto Y, Uchida D, Matsumoto K, Yamamoto N, Horiguchi S, Tsutsumi K, Okada H. A Multicenter, Prospective, Randomized Controlled Trial Evaluating the Efficacy of Rectal Diclofenac and Sublingual Nitrate as a Combined Prophylactic Treatment for Post-ERCP Pancreatitis. Acta Med Okayama. 2017 Aug;71(4):357-362. doi: 10.18926/AMO/55314. PMID: 28824193.
Copy Download .nbib Format: NLM
Benralizumab (Fasenra) for Severe Eosinophilic Asthma.

JAMA

[No authors listed]
PMID: 29634828
JAMA. 2018 Apr 10;319(14):1501-1502. doi: 10.1001/jama.2018.3609.

No abstract available.

Cite
Benralizumab (Fasenra) for Severe Eosinophilic Asthma. JAMA. 2018;319(14):1501-1502doi: 10.1001/jama.2018.3609.
(2018). Benralizumab (Fasenra) for Severe Eosinophilic Asthma. JAMA, 319(14), 1501-1502. https://doi.org/10.1001/jama.2018.3609
"Benralizumab (Fasenra) for Severe Eosinophilic Asthma." JAMA vol. 319,14 (2018): 1501-1502. doi: https://doi.org/10.1001/jama.2018.3609
Benralizumab (Fasenra) for Severe Eosinophilic Asthma. JAMA. 2018 Apr 10;319(14):1501-1502. doi: 10.1001/jama.2018.3609. PMID: 29634828.
Copy Download .nbib Format: NLM
Determination of Trace Amounts of Lead Using the Flotation-spectrophotometric method.

Analytical chemistry insights

Shiri S, Delpisheh A, Haeri A, Poornajaf A, Golzadeh B, Shiri S.
PMID: 30543271
Anal Chem Insights. 2011 Mar 01;6:15-20. doi: 10.4137/ACI.S5948. eCollection 2011.

The present study describes a simple and highly selective method for separation, preconcentration and spectrophotometric determination of extremely low concentrations of lead. It is based on flotation of a complex of Pb

Cite
Shiri S, Delpisheh A, Haeri A, et al. Determination of Trace Amounts of Lead Using the Flotation-spectrophotometric method. Anal Chem Insights. 2011;6:15-20doi: 10.4137/ACI.S5948.
Shiri, S., Delpisheh, A., Haeri, A., Poornajaf, A., Golzadeh, B., & Shiri, S. (2011). Determination of Trace Amounts of Lead Using the Flotation-spectrophotometric method. Analytical chemistry insights, 615-20. https://doi.org/10.4137/ACI.S5948
Shiri, Sabah, et al. "Determination of Trace Amounts of Lead Using the Flotation-spectrophotometric method." Analytical chemistry insights vol. 6 (2011): 15-20. doi: https://doi.org/10.4137/ACI.S5948
Shiri S, Delpisheh A, Haeri A, Poornajaf A, Golzadeh B, Shiri S. Determination of Trace Amounts of Lead Using the Flotation-spectrophotometric method. Anal Chem Insights. 2011 Mar 01;6:15-20. doi: 10.4137/ACI.S5948. eCollection 2011. PMID: 30543271; PMCID: PMC3074207.
Copy Download .nbib Format: NLM
Republished: Statin-induced delayed rhabdomyolysis.

Drug and therapeutics bulletin

Sharma U.
PMID: 31806589
Drug Ther Bull. 2020 Feb;58(2):30-31. doi: 10.1136/dtb.2019.231125rep. Epub 2019 Dec 05.

No abstract available.

Cite
Sharma U. Republished: Statin-induced delayed rhabdomyolysis. Drug Ther Bull. 2019;58(2):30-31doi: 10.1136/dtb.2019.231125rep.
Sharma, U. (2020). Republished: Statin-induced delayed rhabdomyolysis. Drug and therapeutics bulletin, 58(2), 30-31. https://doi.org/10.1136/dtb.2019.231125rep
Sharma, Umesh. "Republished: Statin-induced delayed rhabdomyolysis." Drug and therapeutics bulletin vol. 58,2 (2020): 30-31. doi: https://doi.org/10.1136/dtb.2019.231125rep
Sharma U. Republished: Statin-induced delayed rhabdomyolysis. Drug Ther Bull. 2020 Feb;58(2):30-31. doi: 10.1136/dtb.2019.231125rep. Epub 2019 Dec 05. PMID: 31806589.
Copy Download .nbib Format: NLM
Brexanolone (Zulresso) for Postpartum Depression.

JAMA

[No authors listed]
PMID: 31265098
JAMA. 2019 Jul 02;322(1):73-74. doi: 10.1001/jama.2019.6622.

No abstract available.

Cite
Brexanolone (Zulresso) for Postpartum Depression. JAMA. 2019;322(1):73-74doi: 10.1001/jama.2019.6622.
(2019). Brexanolone (Zulresso) for Postpartum Depression. JAMA, 322(1), 73-74. https://doi.org/10.1001/jama.2019.6622
"Brexanolone (Zulresso) for Postpartum Depression." JAMA vol. 322,1 (2019): 73-74. doi: https://doi.org/10.1001/jama.2019.6622
Brexanolone (Zulresso) for Postpartum Depression. JAMA. 2019 Jul 02;322(1):73-74. doi: 10.1001/jama.2019.6622. PMID: 31265098.
Copy Download .nbib Format: NLM
Corrigendum to "Introduction to the HUPO 2015 Special Issue" [J. Proteomics (2016) 1-2].

Journal of proteomics

Borchers CH, Thibault P.
PMID: 28062015
J Proteomics. 2017 Jan 30;152:355-356. doi: 10.1016/j.jprot.2016.12.005.

No abstract available.

Cite
Borchers CH, Thibault P. Corrigendum to "Introduction to the HUPO 2015 Special Issue" [J. Proteomics (2016) 1-2]. J Proteomics. 2017;152:355-356doi: 10.1016/j.jprot.2016.12.005.
Borchers, C. H., & Thibault, P. (2017). Corrigendum to "Introduction to the HUPO 2015 Special Issue" [J. Proteomics (2016) 1-2]. Journal of proteomics, 152355-356. https://doi.org/10.1016/j.jprot.2016.12.005
Borchers, Christoph H, and Thibault, Pierre. "Corrigendum to "Introduction to the HUPO 2015 Special Issue" [J. Proteomics (2016) 1-2]." Journal of proteomics vol. 152 (2017): 355-356. doi: https://doi.org/10.1016/j.jprot.2016.12.005
Borchers CH, Thibault P. Corrigendum to "Introduction to the HUPO 2015 Special Issue" [J. Proteomics (2016) 1-2]. J Proteomics. 2017 Jan 30;152:355-356. doi: 10.1016/j.jprot.2016.12.005. PMID: 28062015.
Copy Download .nbib Format: NLM
Drugs for Tobacco Dependence.

JAMA

[No authors listed]
PMID: 30193274
JAMA. 2018 Sep 04;320(9):926-927. doi: 10.1001/jama.2018.12463.

No abstract available.

Cite
Drugs for Tobacco Dependence. JAMA. 2018;320(9):926-927doi: 10.1001/jama.2018.12463.
(2018). Drugs for Tobacco Dependence. JAMA, 320(9), 926-927. https://doi.org/10.1001/jama.2018.12463
"Drugs for Tobacco Dependence." JAMA vol. 320,9 (2018): 926-927. doi: https://doi.org/10.1001/jama.2018.12463
Drugs for Tobacco Dependence. JAMA. 2018 Sep 04;320(9):926-927. doi: 10.1001/jama.2018.12463. PMID: 30193274.
Copy Download .nbib Format: NLM
Showing 37 to 48 of 165 entries